Breast Cancer Track
Hereditary Breast Cancer:
Genetic Testing and Management of High Risk Women
Judy E. Garber, MD, MPH
Management of HER2 Positive and Triple-Negative Breast Cancers
Eric P. Winer, MD
Management of ER Positive Breast Cancers
Harold J. Burstein, MD, PhD
Panel Discussion
All Faculty
Supportive Care Track
Palliative Care for Cancer Patients:
Symptom Management and Communication Challenges
Janet L. Abrahm, MD
Caring for Cancer Survivors:
A Comprehensive Approach
Ann H. Partridge, MD, MPH
Genitourinary Cancers Track
Advanced Prostate Cancer:
The Evolving Landscape
Philip W. Kantoff, MD
Bladder and Renal Cancers:
Preliminary Considerations for Integrating Next Generation Therapeutics
Robert Dreicer, MD
Head, Neck and Lung Cancers Track
Head and Neck and Thyroid Cancers:
Recent Advances and Current Management Strategies
Robert I. Haddad, MD
Lung Cancer:
Personalized Approaches to Non-Small Cell and Small Cell Lung Cancer
Bruce E. Johnson, MD
|
Melanoma Cancer Track
Malignant Melanoma:
Multimodality Strategies that Improve Clinical Outcomes
F. Steven Hodi Jr., MD
Panel Discussion
All Faculty
Gynecologic Oncology Track
Lecture Title To Be Determined
Ursula A. Matulonis, MD
Gastrointestinal Cancer Track
Creating a New Standard for Esophageal, Gastric, and Pancreatic Cancers
Peter C. Enzinger, MD
Familial Gastrointestinal Cancers:
Current Guidelines for Screening, Diagnosis, and Management
Sapna Syngal, MD, MPH
Leveraging Genomic and Epidemiologic Findings Toward Reducing Colorectal Cancer Risk and Mortality
Charles S. Fuchs, MD, MPH
Colorectal Cancer:
The Status of Systemic Treatment for Adjuvant and Metastatic Disease Settings
Robert J. Mayer, MD
Panel Discussion
All Faculty
Hematologic Malignancies Track
Making Sense of the Myriad Treatment Options for Non-Hodgkin and Hodgkin Lymphoma
Arnold S. Freedman, MD
New and Emerging Therapies in Myeloid Malignancies:
Current Practice Paradigms
Daniel J. DeAngelo, MD, PhD
Myeloproliferative Neoplasms:
Natural History, Genetic Risk Factors, Advances in Treatment
Ayalew Tefferi, MD
Multiple Myeloma:
Emerging Diagnostic and Therapeutic Paradigms
Kenneth C. Anderson, MD
Chronic Lymphocytic Leukemia:
Current Best Management in the Era of Targeted Therapy
John C. Byrd, MD
Panel Discussion
All Faculty
|